A D S Diagnostic Ltd vs Zydus Lifesciences Limited
A side-by-side comparison of A D S Diagnostic Ltd (523031) and Zydus Lifesciences Limited (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Zydus Lifesciences Limited leads 523031 vs ZYDUSLIFE on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability13
- Growth20
- Size & financial health13
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
ZYDUSLIFE takes 3/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
523031 takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
ZYDUSLIFE takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Stock is trading at 0.33 times its book value", "Stock is providing a good dividend yield of 8.82%.", "Company has been maintaining a healthy dividend payout of 17.4%", "Debtor days have improved from 80.2 to 63.7 days.", "Company's working capital requirements have reduced from 76.9 days to 61.1 days"]
- − ["Company's cost of borrowing seems high"]
- + ["Company has delivered good profit growth of 18.6% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 20.9%"]
- − []
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.